US 7579188
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
granted A61KA61K35/12A61P
Quick answer
US patent 7579188 (Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury) held by The Regents of the University of California expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K35/12, A61P, A61P25/00, A61P25/28